Qu Biologics Inc.

07/23/2025

Exciting news! We've officially completed enrolment for the RESILIENCE Study — a Phase 2 clinical trial evaluating our novel immunotherapy (QBKPN SSI) to restore immune function in older adults. This is a major step toward improving healthy longevity.

Read more about what this means for aging, immune health, and the future of medicine: https://tinyurl.com/2hrnda3b

VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific...

07/01/2025

Wishing everyone a Happy Canada Day from all of us at Qu Biologics!
We're proud to call Canada home - a place where innovation, diversity, and community thrive. Here's to a day of celebration, connection, and gratitude.

06/23/2025

We’re hosting a scientific café on Thursday for those interested in learning about the important role of natural immunity in health and aging. Join Dr. Hal Gunn and Dr. Shirin Kalyan for this free event at Trout Lake Community Centre!

Date: June 26, Thursday
Time: 2:00 PM - 3:00 PM
Location: Trout Lake Community Centre – Lakewood Room
3360 Victoria Dr, Vancouver, BC V5N 5X2

To register, purchase your free ticket here: https://www.eventbrite.ca/e/1008023494407?aff=oddtdtcreator
OR please leave a voicemail at 778-383-1308

Light refreshments provided. Tailored for people 65+
We look forward to seeing you there!

Let's dive into how our body's natural defenses play a crucial role in keeping us healthy as we age.

06/05/2025

Boost Your Immunity: Join Dr. Hal Gunn and Dr. Shirin Kalyan for a presentation on Strengthening Your Immune System - Tailored for People 65+

Date: June 26, Thursday
Time: 2:00 PM - 3:00 PM
Venue: Trout Lake Community Centre – Lakewood Room
Address: 3350 Victoria Drive, Vancouver, BC

For more information and to register: Please leave a message at 778-383-1308

This is a free event. Light refreshments provided.

02/19/2025

Interested in learning about the important role of natural immunity in health and aging? Join us this Friday at South Granville Seniors Centre!

Date: February 21, Friday
Time: 1:00 PM - 2:00 PM
Location: 1420 W 12 Ave., Vancouver, BC
Tailored for people 65+

https://www.facebook.com/share/p/15go6izydK/

02/10/2025

Qu Biologics Inc. is pleased to report exciting data demonstrating that its QBECO immunomodulator lowers a key indicator of senescence in the liver of animals with established obesity.

The study was conducted in collaboration with Dr. Jonathan Schertzer, who holds a Canada Research Chair in Metabolic Inflammation and is a Professor in the Department of Biochemistry and Biomedical Sciences at McMaster Faculty of Health Sciences.

Learn more in our latest press release:
https://tinyurl.com/ys2c57j6

BURNABY, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific...

02/03/2025

Thank you to everyone who joined us for our presentation on natural immunity and aging at Rideau Retirement Residence! For those who couldn’t make it, we’re hosting another session at Thunderbird Community Centre tomorrow, February 4. This event is open to the public, and we’d love to see you there!

Date: February 4, 2025
Time: 12:30 PM
Location: Thunderbird Community Centre
Tailored for people 65+

01/27/2025

Boost Your Immunity: Join Dr. Hal Gunn for a Presentation on Strengthening Your Immune System - Tailored for People 65+

Date: January 30, 2025
Time: 2:00 PM
Location: Rideau Residence
RSVP: Call/ Text Lianne at 778-837-7031

01/06/2025

Qu Biologics Inc. is pleased to report exciting data demonstrating that Qu Biologics’ QBECO SSI markedly improves fatty liver disease and its deleterious consequences in an animal model of preexisting obesity. The study was conducted in collaboration with Dr. Jon Schertzer who holds a Canada Research Chair in Metabolic Inflammation and is a Professor in the Department of Biochemistry and Biomedical Sciences at McMaster University.
Learn more in our latest press release:

BURNABY, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific...

12/16/2024

Qu Biologics Inc. is pleased to report exciting survival data using a combination of Qu Biologics’ QBECO SSI and CAR T-cell therapy in an animal model of aggressive cancer. The study was conducted in collaboration with the NUS Yong Loo Lin School of Medicine.

Prof. Nicholas Gascoigne, an internationally recognized T-cell researcher, whose lab at the National University of Singapore performed this research, stated, "While early, the data is very promising. If CAR T-cell therapy could be effectively applied to solid tumors, it would transform the field of oncology."

Learn more in our latest press release: https://www.globenewswire.com/news-release/2024/12/16/2997462/0/en/Qu-Biologics-Site-Specific-Immunomodulator-Enables-CAR-T-cell-Cancer-Efficacy-in-Solid-Tumor.html

BURNABY, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific...

10/18/2024

Important Update: The October 23rd webinar on natural immunity and aging has been postponed. We’ll announce the new date soon, so please stay tuned.

Keep following us for updates on this informative presentation. Thank you for your patience and support!